TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME

Details for Australian Patent Application No. 2001271264 (hide)

Owner PHARMACIA AND UPJOHN COMPANY

Inventors ROBERTSON, David, W.; MCCALL, Robert, B.; MARSHALL, Robert, C.

Pub. Number AU-A-2001271264

PCT Pub. Number WO2002/083141

Priority PCT/US01/10806 17.04.01 US

Filing date 11 July 2001

Wipo publication date 28 October 2002

International Classifications

A61K 031/505 - Pyrimidines

A61K 031/48 - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 031/47 - Quinolines

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 043/00 Drugs for specific purposes, not provided for in groups

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2001271264

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001271265-Novel c-4 substituted retinoids

2001271263